 |
2-0-Butyryl-1-0-octyl-myo-inositol 3,4,5,6-tetrakisphosphate |
|---|---|
| Trade Name | |
| Orphan Indication | Cystic fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 2003-08-15 00:00:00 |
| Sponsor | Inologic, Inc.;101 Elliott Ave., West;Seattle, Washington, 98119 |
Related Access Program